Drug profile · INN
nepafenac
NEVANAC
nepafenac (NEVANAC) is a cyclooxygenase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — nepafenac
- US status
- approved
- Class
- Sensory organs (S01)
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
nepafenac (NEVANAC) is a cyclooxygenase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is nepafenac?
nepafenac (NEVANAC) is a cyclooxygenase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for nepafenac?
NEVANAC is a marketed brand name for nepafenac. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nepafenac?
nepafenac has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.